Overview
Top Medical Research Studies
We found that vitamin D3 has a unique ability to suppress M1 macrophage polarization, a process that intensifies inflammation and is linked to RA symptoms. The treatment reduced levels of various inflammatory markers in macrophages, which are crucial players in our immune response.
In controlled experiments using THP-1 cells (a type of human immune cell), vitamin D3 enhanced the expression of fructose-1,6-bisphosphatase 1 (FBP1). This interaction was significant because FBP1 helps manage the degradation of another protein called PKR, which is involved in the inflammatory response.
By interacting with FBP1 and PKR, vitamin D3 diminishes the inflammatory activity of macrophages, suggesting a pathway for reducing arthritis symptoms. We also observed promising effects in TNF-transgenic mice, where vitamin D3 treatment alleviated arthritic manifestations and promoted a healthier macrophage profile in cells taken from swollen joints.
Overall, our findings affirm the potential of vitamin D3 as a beneficial treatment option for individuals struggling with rheumatoid arthritis.
Among the 68 participants—primarily women—we observed that the group taking vitamin D showed noticeable improvements in their overall wellness. Notably, their vitamin D levels increased significantly compared to those who did not receive the supplement. This rise in vitamin D was linked to better scores on fatigue assessments, meaning patients felt less tired.
Although both groups had similar characteristics at the start of the study, the outcome highlighted a clear benefit of vitamin D. We found that higher vitamin D levels correlated with improved fatigue, encouraging evidence for considering vitamin D as part of RA treatment plans. However, no significant changes were observed in disease activity scores, indicating that while vitamin D helps with fatigue, it may not directly alter the course of RA.
Participants were split into two groups: one group received a weekly boost of 50,000 IU of vitamin D3, while the other group continued their treatment without any vitamin D3 supplementation. Over a period of 12 weeks, we monitored changes in their symptoms and overall well-being.
Our results revealed something quite remarkable. The group taking vitamin D3 reported notable improvements in fatigue levels compared to those who did not receive the supplement. Specifically, the patients receiving vitamin D3 achieved normal fatigue scores, suggesting their energy levels were significantly better. Additionally, we observed a positive link between higher vitamin D levels and a reduction in fatigue symptoms.
However, there wasn't a significant change in measures of disease activity, indicating that while vitamin D3 can help with fatigue, it may not directly influence the disease's inflammatory aspects in RA patients. Overall, the findings highlight vitamin D3's role in improving the quality of life for individuals battling rheumatoid arthritis through alleviation of fatigue, even when their disease activity remains unchanged.
Most Useful Reviews
Medical Researches
- All Researches
We particularly noted significant associations between sufficient vitamin D levels and lower mortality rates from heart disease and certain cancers. In fact, individuals with adequate vitamin D levels showed a striking 40% reduced risk of dying compared to those classified as vitamin D deficient.
Given these results, it's clear that vitamin D plays a vital role in the health of those with rheumatoid arthritis, especially for older adults. We suggest that maintaining a minimum level of 60 nmol/L could be crucial for improving outcomes in this population.
To sum up, the evidence suggests that supporting adequate vitamin D levels might just be a key factor in enhancing longevity and overall health in individuals living with rheumatoid arthritis.
Among the 68 participants—primarily women—we observed that the group taking vitamin D showed noticeable improvements in their overall wellness. Notably, their vitamin D levels increased significantly compared to those who did not receive the supplement. This rise in vitamin D was linked to better scores on fatigue assessments, meaning patients felt less tired.
Although both groups had similar characteristics at the start of the study, the outcome highlighted a clear benefit of vitamin D. We found that higher vitamin D levels correlated with improved fatigue, encouraging evidence for considering vitamin D as part of RA treatment plans. However, no significant changes were observed in disease activity scores, indicating that while vitamin D helps with fatigue, it may not directly alter the course of RA.
Participants were split into two groups: one group received a weekly boost of 50,000 IU of vitamin D3, while the other group continued their treatment without any vitamin D3 supplementation. Over a period of 12 weeks, we monitored changes in their symptoms and overall well-being.
Our results revealed something quite remarkable. The group taking vitamin D3 reported notable improvements in fatigue levels compared to those who did not receive the supplement. Specifically, the patients receiving vitamin D3 achieved normal fatigue scores, suggesting their energy levels were significantly better. Additionally, we observed a positive link between higher vitamin D levels and a reduction in fatigue symptoms.
However, there wasn't a significant change in measures of disease activity, indicating that while vitamin D3 can help with fatigue, it may not directly influence the disease's inflammatory aspects in RA patients. Overall, the findings highlight vitamin D3's role in improving the quality of life for individuals battling rheumatoid arthritis through alleviation of fatigue, even when their disease activity remains unchanged.
We found that vitamin D3 has a unique ability to suppress M1 macrophage polarization, a process that intensifies inflammation and is linked to RA symptoms. The treatment reduced levels of various inflammatory markers in macrophages, which are crucial players in our immune response.
In controlled experiments using THP-1 cells (a type of human immune cell), vitamin D3 enhanced the expression of fructose-1,6-bisphosphatase 1 (FBP1). This interaction was significant because FBP1 helps manage the degradation of another protein called PKR, which is involved in the inflammatory response.
By interacting with FBP1 and PKR, vitamin D3 diminishes the inflammatory activity of macrophages, suggesting a pathway for reducing arthritis symptoms. We also observed promising effects in TNF-transgenic mice, where vitamin D3 treatment alleviated arthritic manifestations and promoted a healthier macrophage profile in cells taken from swollen joints.
Overall, our findings affirm the potential of vitamin D3 as a beneficial treatment option for individuals struggling with rheumatoid arthritis.
Our findings demonstrated that 20(OH)D3 significantly suppressed clinical signs of arthritis and reduced joint damage. We observed a decrease in harmful lymphocyte subsets, such as CD4 T cells and CD19 B cells, which are responsible for inflammatory responses in RA. Notably, treatment with 20(OH)D3 resulted in a better balance of regulatory T cells compared to other T cell types, and also a reduction in anti-CII antibodies, critical players in joint damage.
The results of this study suggest that by lowering pro-inflammatory cytokines and antibodies, 20(OH)D3 effectively shields the cartilage and bone from destruction. This positions 20(OH)D3 as a potential candidate for treating RA and possibly other autoimmune disorders, warranting further investigation.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects the joints but can also have systemic implications, impacting multiple body systems, including skin, eyes, lungs, heart, and blood vessels. It occurs when the immune system mistakenly attacks the synovium—the lining of the membranes that surround the joints—leading to inflammation, pain, and swelling. Over time, if left untreated, RA can erode bone and cartilage, resulting in diminished joint function and mobility. The precise cause of RA is still uncertain, but factors such as genetics, hormonal changes, and environmental triggers are believed to play a role.
Individuals with RA often experience flares—periods of increased disease activity and symptom severity—followed by remission where symptoms may improve. Common signs and symptoms include pain, tenderness, swelling, and stiffness in the joints, particularly in the morning or after prolonged inactivity. While there is no cure for rheumatoid arthritis, a combination of medication, physical therapy, and lifestyle adjustments can significantly manage symptoms and improve the quality of life. Effective treatment plans often include disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, as well as biological agents that target specific pathways in the inflammatory process.
Vitamin D is a fat-soluble vitamin that's essential for maintaining healthy bones and teeth, supporting immune system function, and facilitating normal cell growth and development. It plays a crucial role in calcium absorption in the gut, which is vital for bone health. Unlike most vitamins, our bodies can produce Vitamin D when exposed to sunlight, specifically UVB rays, which is why it’s often referred to as the "sunshine vitamin." However, depending on your geographical location, lifestyle, and skin type, getting sufficient Vitamin D from the sun alone can be challenging, particularly during the winter months.
In addition to sunlight, Vitamin D can be obtained from certain foods such as fatty fish (like salmon and mackerel), fish liver oils, and fortified foods like milk and cereals. Some individuals may also consider supplements, especially if they're at risk for deficiency. Insufficient vitamin D levels are linked to various health issues, including rickets in children, osteomalacia in adults, and even an increased risk of chronic diseases. Regularly checking your vitamin D levels and consulting with a healthcare professional can help ensure you're meeting your needs for optimal health.
Emerging research suggests that Vitamin D may play a role in managing Rheumatoid Arthritis (RA). Studies indicate that individuals with RA often have lower levels of Vitamin D, and supplementation may help in regulating the immune system and reducing inflammation. While Vitamin D by itself is not a cure for RA, it may contribute to better overall joint health and function alongside traditional therapies.
It’s essential to remember that before starting any supplementation, you should consult your healthcare provider. They can provide guidance on appropriate dosages and monitor your Vitamin D levels to ensure you’re not at risk of toxicity. Ultimately, while Vitamin D may provide some benefits for individuals with Rheumatoid Arthritis, it should be approached as a complement to established treatment protocols rather than a standalone solution.
According to user reviews, the time it takes to see results from taking vitamin D-3 for rheumatoid arthritis can vary, but many individuals report noticing improvements within a few weeks to a few months. One user mentioned that after three months of use, their rheumatoid factor had significantly decreased, indicating a positive change in their condition (Read Review). Another reviewer shared that they had experienced a reduction in inflammation and pain, allowing them to be more active after incorporating this supplement into their routine, suggesting that initial benefits can be felt relatively quickly (Read Review).
However, results seem to be subjective, and not all users report the same level of effectiveness. For instance, one reviewer stated they haven't felt any benefits and are unsure about the supplement's absorption (Read Review). So, while many users have found value in taking vitamin D-3 for rheumatoid arthritis, it appears that individual experiences may differ significantly in terms of timeline and efficacy.
Recent scientific research suggests that vitamin D supplementation may play a beneficial role in the management of rheumatoid arthritis (RA). A systematic review and meta-analysis indicated that vitamin D could significantly reduce disease activity, as measured by the Disease Activity Score 28 (DAS-28), while also impacting markers of inflammation such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) [1]. Additionally, studies have pointed to a link between low vitamin D levels and increased disease severity and fatigue in RA patients, highlighting the importance of adequate vitamin D levels in potentially enhancing overall well-being [7] [16].
However, it’s essential to note that while vitamin D shows promise, the evidence for its direct impact on disease progression remains mixed. Some studies have shown improvements in fatigue without significant changes in disease activity scores, suggesting that vitamin D is more effective at alleviating certain symptoms rather than directly altering RA's inflammatory processes [16]. Overall, while vitamin D supplementation appears to be a valuable addition to RA management strategies, further research is necessary to determine optimal dosages and understand its comprehensive effects on this complex condition.
Based on user reviews, many individuals report experiencing notable improvements in their symptoms after incorporating vitamin D-3 into their routine for rheumatoid arthritis. One user mentioned a remarkable recovery from serious illnesses, including rheumatoid arthritis and bronchitis, highlighting an increase in energy, mood, and overall vitality (Read Review). Similarly, another user with a 27-year history of rheumatoid arthritis stated that their inflammation and pain have significantly lessened, allowing for increased physical activity and a better appetite (Read Review). Other reviewers reported similar experiences of reduced inflammation and improved joint function, underscoring the potential benefits of vitamin D-3 in managing rheumatoid arthritis symptoms (Read Review) (Read Review).
However, it is essential to note that individual results can vary greatly. While numerous users praised the positive impact of vitamin D-3, there are also experiences of skepticism, as one reviewer expressed uncertainty about the supplement's effectiveness and absorption (Read Review). Therefore, while many have reported beneficial outcomes, it's crucial for individuals to assess their responses and consult with healthcare professionals when considering vitamin D-3 for their specific conditions.
Based on user reviews, many individuals report positive experiences when combining vitamin D-3 with their regimen for managing rheumatoid arthritis. One user shared that after taking vitamin D-3, they experienced remarkable improvements, including increased energy and reduced pain and inflammation, which allowed them to be more active (Read Review). Similarly, another long-term arthritis sufferer noted a significant decrease in inflammation and pain, crediting vitamin D-3 for their newfound ability to maintain a good appetite and engage in more physical activity (Read Review).
Additionally, users have reported that consistent use of vitamin D-3 not only contributes to lower inflammation in joints but also assists in regulating overall health, thereby reinforcing its role in their arthritis management plans (Read Review) (Read Review). However, it’s important to note that individual experiences can vary. While many users found value in the supplement, there were some who reported no benefits or uncertainties regarding its absorption, indicating that vitamin D-3 may not be universally effective for all (Read Review).
Based on user reviews, the consensus on the right dose of Vitamin D for treating rheumatoid arthritis varies, with many users highlighting positive experiences with dosages around 2000 international units (IUs). One user specifically noted that this dosage helps maintain vitamin D levels while enhancing immunity and supporting a healthy inflammatory response, which is beneficial for managing their rheumatoid arthritis symptoms (Read Review). Others have reported significant improvements in inflammation and pain after using NOw Foods Vitamin D-3, although specific dosages were not always mentioned (Read Review).
Additionally, it is essential to be cautious with Vitamin D intake, as some users have warned against overdosing. One review stressed that while the vitamin alleviates joint diseases like rheumatoid arthritis, it is crucial not to exceed recommended amounts (Read Review). Overall, while many users have posted their success stories with Vitamin D supplementation for rheumatoid arthritis, individual needs may vary, and it is advisable for users to consult their healthcare providers for personalized recommendations.
The findings were quite promising. Vitamin D showed a significant positive effect on the Disease Activity Score 28 (DAS-28), which is a measure of RA activity. The weighted mean difference (WMD) observed was -0.83, indicating that vitamin D helped reduce overall disease activity. Additionally, we noted improvements in other markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), both of which are indicators of inflammation.
While vitamin D effectively raised serum vitamin D levels, it didn't have a significant impact on the health assessment questionnaire (HAQ) or pain scores (VAS-pain). This suggests that while vitamin D may help manage inflammation and disease activity, it doesn't necessarily translate into improved functionality or pain relief in every aspect.
Overall, our analysis suggests that vitamin D supplementation can be beneficial for managing rheumatoid arthritis, although we still need to figure out the best dosages and duration of treatment. This gap in knowledge poses an important question for future research.
Interestingly, we found that a significant number of participants, 66.2%, reported experiencing fatigue. Our analysis revealed that vitamin D deficiency was notably associated with fatigue, presenting an odds ratio of 6.38. This suggests that those with low vitamin D levels were at a higher risk of experiencing fatigue.
Additionally, factors related to disease activity and sleep impairment also played critical roles. Both were found to be significantly associated with fatigue levels. Overall, while vitamin D appears to be an important factor influencing fatigue in RA, it does not exist in isolation and interacts with other disease-related aspects.
Participants were split into two groups: one group received a weekly boost of 50,000 IU of vitamin D3, while the other group continued their treatment without any vitamin D3 supplementation. Over a period of 12 weeks, we monitored changes in their symptoms and overall well-being.
Our results revealed something quite remarkable. The group taking vitamin D3 reported notable improvements in fatigue levels compared to those who did not receive the supplement. Specifically, the patients receiving vitamin D3 achieved normal fatigue scores, suggesting their energy levels were significantly better. Additionally, we observed a positive link between higher vitamin D levels and a reduction in fatigue symptoms.
However, there wasn't a significant change in measures of disease activity, indicating that while vitamin D3 can help with fatigue, it may not directly influence the disease's inflammatory aspects in RA patients. Overall, the findings highlight vitamin D3's role in improving the quality of life for individuals battling rheumatoid arthritis through alleviation of fatigue, even when their disease activity remains unchanged.
References
- Ranjbar M, Rahimlou M, Fallah M, Djafarian K, Mohammadi H. Effects of vitamin D supplementation in patients with rheumatoid arthritis: A systematic review and meta-analysis. Heliyon. 2025;11:e42463. doi:10.1016/j.heliyon.2025.e42463
- Rafati A, Ramezani R, Esmaeili Gouvarchin Ghaleh H, Bahrami S, Alvanegh AG, et al. Calcitriol Treated Mesenchymal Stem Cells Modulated Immune Response in Collagen-Induced Rheumatoid Arthritis in BALB/c Mice. Transplant Proc. 2025;57:355. doi:10.1016/j.transproceed.2024.12.020
- Hijjawi N, Tout FS, Azaizeh B, Aljaafreh B. The role of vitamins D, B12, C, and K in modulating inflammation and disease management in rheumatoid arthritis: a comprehensive review. Clin Rheumatol. 2025;44:591. doi:10.1007/s10067-024-07285-9
- Wielińska J, Górna K, Świerkot J, Bugaj B, Kolossa K, et al. Polymorphic Variants in the Vitamin D Receptor and Clinical Parameters of Rheumatoid Arthritis Patients Undergoing Anti-TNF Treatment. Arch Immunol Ther Exp (Warsz). 2024;72. doi:10.2478/aite-2024-0023
- Feng Y, Zhu P, Yan D, Wang X, Chen C, et al. Implications of vitamin D levels or status for mortality in rheumatoid arthritis: analysis of 2001-2018 data from the National Health and Nutrition Examination Survey. Front Immunol. 2024;15:1425119. doi:10.3389/fimmu.2024.1425119
- Choudhury C, Sahib A, Karmakar P, Kar S. Correlation of Serum Vitamin D and High-Density Lipoprotein (HDL) Cholesterol Levels With Disease Activity in Rheumatoid Arthritis: A Single-Center Experience From Eastern India. Cureus. 2024;16:e69333. doi:10.7759/cureus.69333
- Yadav A, Gera C, Avasthi GL. Multifactorial Nature of Fatigue in North Indian Rheumatoid Arthritis Patients. Mediterr J Rheumatol. 2024;35:241. doi:10.31138/mjr.150124.mnf
- Shufang M, Xiaojiao H, Yinhong K. Pro-inflammatory cytokine IL-21 correlates with the reactive oxygen species and 25-hydroxy vitamin D in rheumatoid arthritis patients. Immun Inflamm Dis. 2024;12:e1308. doi:10.1002/iid3.1308
- Elfituri S. The effects of vitamin D supplementation on disease activity and fatigue in Libyan rheumatoid arthritis patients. Reumatologia. 2024;62:109. doi:10.5114/reum/187391
- Deane KD. Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention. Curr Opin Rheumatol. 2024;36:225. doi:10.1097/BOR.0000000000001013
- Cieślewicz A, Korzeniowska K, Grabańska-Martyńska K, Jabłecka A, Hrycaj P. Seasonal and Treatment-Related Variation in 25-Hydroxy Vitamin D Concentration in Patients with Rheumatoid Arthritis. J Clin Med. 2024;13. doi:10.3390/jcm13040973
- Rivera-Escoto M, Campos-López B, Pesqueda-Cendejas K, Ruiz-Ballesteros AI, Mora-García PE, et al. Analysis of Potential Vitamin D Molecule Biomarkers: Association of Calcitriol and Its Hydroxylation Efficiency Ratio with Cardiovascular Disease Risk in Rheumatoid Arthritis Patients. Biomedicines. 2024;12. doi:10.3390/biomedicines12020273
- Malakooti SK, Siddiqui H, Wilson B, Bej T, O'Mara M, et al. Higher Vitamin D Levels before Methotrexate Therapy Initiation Are Associated with Lower Subsequent Mortality in Patients with Rheumatoid Arthritis. Nutrients. 2024;16. doi:10.3390/nu16030401
- Rafati A, Ramezani R, Esmaeili Gouvarchin Ghaleh H, Bahrami S, Alvanegh AG, et al. Calcitriol Treated Mesenchymal Stem Cells Modulated Immune Response in Collagen-Induced Rheumatoid Arthritis in BALB/c Mice. Transplant Proc. 2025;57:355. doi:10.1016/j.transproceed.2024.12.020
- Wielińska J, Górna K, Świerkot J, Bugaj B, Kolossa K, et al. Polymorphic Variants in the Vitamin D Receptor and Clinical Parameters of Rheumatoid Arthritis Patients Undergoing Anti-TNF Treatment. Arch Immunol Ther Exp (Warsz). 2024;72. doi:10.2478/aite-2024-0023
- Elfituri S. The effects of vitamin D supplementation on disease activity and fatigue in Libyan rheumatoid arthritis patients. Reumatologia. 2024;62:109. doi:10.5114/reum/187391
- Huovinen J, Palosaari S, Pesonen P, Huhtakangas JA, Lehenkari P. 1,25(OH)D and its analogue calcipotriol inhibit the migration of human synovial and mesenchymal stromal cells in a wound healing model - A comparison with glucocorticoids. J Steroid Biochem Mol Biol. 2023;233:106373. doi:10.1016/j.jsbmb.2023.106373
- Zhu W, Zhu Y, Zhang S, Zhang W, Si Z, et al. 1,25-Dihydroxyvitamin D regulates macrophage activation through FBP1/PKR and ameliorates arthritis in TNF-transgenic mice. J Steroid Biochem Mol Biol. 2023;228:106251. doi:10.1016/j.jsbmb.2023.106251
- Zou J, Zhu L, Yang J, Feng J, Li S, et al. Correlation between vitamin D metabolites and rheumatoid arthritis with osteoporosis by ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). J Bone Miner Metab. 2022;40:696. doi:10.1007/s00774-022-01337-3
- Sakalyte R, Denkovskij J, Bernotiene E, Stropuviene S, Mikulenaite SO, et al. The Expression of Inflammasomes NLRP1 and NLRP3, Toll-Like Receptors, and Vitamin D Receptor in Synovial Fibroblasts From Patients With Different Types of Knee Arthritis. Front Immunol. 2021;12:767512. doi:10.3389/fimmu.2021.767512
- Myers LK, Winstead M, Kee JD, Park JJ, Zhang S, et al. 1,25-Dihydroxyvitamin D3 and 20-Hydroxyvitamin D3 Upregulate LAIR-1 and Attenuate Collagen Induced Arthritis. Int J Mol Sci. 2021;22. doi:10.3390/ijms222413342
- Postlethwaite AE, Tuckey RC, Kim TK, Li W, Bhattacharya SK, et al. 20-Hydroxyvitamin D3, a Secosteroid Produced in Humans, Is Anti-Inflammatory and Inhibits Murine Autoimmune Arthritis. Front Immunol. 2021;12:678487. doi:10.3389/fimmu.2021.678487
- Dobrovolskaya OV, Toroptsova NV, Nikitinskaya OA, Samarkina EY, Cherkasova MV, et al. [Vitamin D status in women with rheumatoid arthritis: frequency of hypovitaminosis, associations with disease activity, body composition and comorbidity]. Ter Arkh. 2021;93:581. doi:10.26442/00403660.2021.05.200790
- Hemshekhar M, Anaparti V, El-Gabalawy H, Mookherjee N. A bioavailable form of curcumin, in combination with vitamin-D- and omega-3-enriched diet, modifies disease onset and outcomes in a murine model of collagen-induced arthritis. Arthritis Res Ther. 2021;23:39. doi:10.1186/s13075-021-02423-z
